•
IN
INMB
INmune Bio Inc. Common stock
polygonBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
43.60M
Volume
369.66K
52W High
$11.64
52W Low
$1.38
Open
$1.65
Prev Close
$1.64
Day Range
1.63 - 1.72
About INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
Latest News
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform
GlobeNewswire Inc.•Dec 5
INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th
GlobeNewswire Inc.•Jul 31
INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
GlobeNewswire Inc.•Jun 26
Inmune Bio re-elects directors, ratifies auditor - Investing.com
Investing.com•Jul 19
Zura Bio initiates exchange offer for warrants By Investing.com - Investing.com
Investing.com•Jul 12
INmune Bio Inc. to Join Russell 3000® Index
GlobeNewswire Inc.•May 30
INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update
GlobeNewswire Inc.•May 9
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update
GlobeNewswire Inc.•Mar 28